[Donor lung availability in the 21st century].
Lung transplantation has become an established treatment for end-stage pulmonary failure refractory to medical management. However, the scarcity of lung grafts and the growing number of candidates has led to an increase in deaths among patients on waiting lists. Despite improvements in donor management, organ preservation, and the use of marginal and cardiac-death donors, only about 20% of candidate lungs are currently being transplanted. A new ex vivo "reconditioning" technique is opening up new perspectives. Indeed, a significant number of rejected lungs can now be retrieved and transplanted with acceptable results. Given the longer storage times provided by this technique, transplantation can be programmed, with better surgical efficiency. In the near future, a new mobile organ-care machine should become available, along with laboratories dedicated to ex vivo reconditioning of all lung grafts before their transplantation.
Souilamas
Redha
R
Hôpital Européen Georges Pompidou (HEGP), 1, rue Leblanc, 75015 Paris. redha.souilamas@egp.aphp.fr
D000818:Animals; D001926:Brain Death; D005602:France; D006323:Heart Arrest; D006801:Humans; D016040:Lung Transplantation / Q000706:statistics & numerical data* / Q000639:trends; D023421:Models, Animal; D009926:Organ Preservation / Q000379:methods; D014019:Tissue Donors / Q000600:supply & distribution*; D020858:Tissue and Organ Harvesting; D009927:Tissue and Organ Procurement; D014850:Waiting Lists